|
|
||||||||
Journal of Lipid Research, Vol 37, 148-158, Copyright © 1996 by Lipid Research, Inc.
M Mark, P Muller, R Maier and B Eisele
Within the cholesterol biosynthesis cascade, the enzyme 2,3- oxidosqualene
cyclase [EC 5.4.99.7] is of special interest due to its dual function:
cyclization of 2,3-monoepoxysqualene to lanosterol and
2,3;22,23-diepoxysqualene to oxylanosterol. Further determination of the
significance of this enzyme for the intracellular cholesterol homeostasis
was done with BIBX 79, a new potent, specific inhibitor of this enzyme. In
HepG2 cells the effects of BIBX 79 on cholesterol biosynthesis,
2,3-oxidosqualene cyclase as well as HMG-CoA reductase activities were
studied. BIBX 79 is a potent inhibitor of sterol biosynthesis in HepG2
cells (IC50 4 x 10(-9) M). No other enzyme within the cholesterol
biosynthesis cascade was significantly inhibited as was evidenced by a
radio HPLC detection system. In contrast to simvastatin, no direct
interaction with HMG-CoA reductase was observed. When incubating HepG2
cells for 16 h with the HMG-CoA reductase inhibitor simvastatin
(10(-6)-10(-10) M) HMG-CoA reductase activity was increased up to 180%.
BIBX 79 did also affect HMG-CoA reductase activity under these conditions:
in concentrations of BIBX 79 "> or =" 10(-9) "< or =" 10(-7) M, where
a partial inhibition of 2,3-oxidosqualene cyclase is observed, HMG-CoA
reductase activity was decreased. However, higher concentrations of BIBX 79
that totally blocked 2,3-oxidosqualene cyclase led to an increase in
HMG-CoA reductase activity. This effect of BIBX 79 on HMG-CoA reductase is
thought to be mainly mediated by oxysterols that are formed by the
cyclization of 2,3;22,23- diepoxysqualene. 2,3;22,23-Diepoxysqualene is
preferentially cyclized by the 2,3-oxidosqualene cyclase and, consequently,
only high inhibitor concentrations will also block
2,3;22,23-diepoxysqualene cyclization. Thus, by partial blockade of this
enzyme, both an inhibition of lanosterol and subsequently cholesterol
formation as well as a concomitant effect on HMG-CoA reductase can be
achieved. Both effects complement each other and lead to an effective
control of cholesterol biosynthesis. It is therefore concluded that
2,3-oxidosqualene cyclase plays a crucial role in the regulation of
intracellular cholesterol homeostasis. 2,3-Oxidosqualene cyclase inhibitors
offer an attractive approach for novel lipid-lowering agents.
ARTICLES
Effects of a novel 2,3-oxidosqualene cyclase inhibitor on the regulation of cholesterol biosynthesis in HepG2 cells
Preclinical Research, Department of Biology, Biberach, Germany.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. Bentinger, M. Tekle, K. Brismar, T. Chojnacki, E. Swiezewska, and G. Dallner Polyisoprenoid Epoxides Stimulate the Biosynthesis of Coenzyme Q and Inhibit Cholesterol Synthesis J. Biol. Chem., May 23, 2008; 283(21): 14645 - 14653. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wong, C. M. Quinn, I. C. Gelissen, and A. J. Brown Endogenous 24(S),25-Epoxycholesterol Fine-tunes Acute Control of Cellular Cholesterol Homeostasis J. Biol. Chem., January 11, 2008; 283(2): 700 - 707. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Telford, S. M. Lipson, P. H. R. Barrett, B. G. Sutherland, J. Y. Edwards, J. D. Aebi, H. Dehmlow, O. H. Morand, and M. W. Huff A Novel Inhibitor of Oxidosqualene:Lanosterol Cyclase Inhibits Very Low-Density Lipoprotein Apolipoprotein B100 (ApoB100) Production and Enhances Low-Density Lipoprotein ApoB100 Catabolism Through Marked Reduction in Hepatic Cholesterol Content Arterioscler. Thromb. Vasc. Biol., December 1, 2005; 25(12): 2608 - 2614. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Cenedella, R. Jacob, D. Borchman, D. Tang, A. R. Neely, A. Samadi, R. P. Mason, and P. Sexton Direct perturbation of lens membrane structure may contribute to cataracts caused by U18666A, an oxidosqualene cyclase inhibitor J. Lipid Res., July 1, 2004; 45(7): 1232 - 1241. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Shenoy, T. A. Spencer, N. A. Mercer-Haines, M. Abdolalipour, W. L. Wurster, M. Runge-Morris, and T. A. Kocarek Induction of CYP3A by 2,3-Oxidosqualene:Lanosterol Cyclase Inhibitors Is Mediated by an Endogenous Squalene Metabolite in Primary Cultured Rat Hepatocytes Mol. Pharmacol., May 1, 2004; 65(5): 1302 - 1312. [Abstract] [Full Text] |
||||
![]() |
S. D. Shenoy, T. A. Spencer, N. A. Mercer-Haines, M. Alipour, M. D. Gargano, M. Runge-Morris, and T. A. Kocarek CYP3A INDUCTION BY LIVER X RECEPTOR LIGANDS IN PRIMARY CULTURED RAT AND MOUSE HEPATOCYTES IS MEDIATED BY THE PREGNANE X RECEPTOR Drug Metab. Dispos., January 1, 2004; 32(1): 66 - 71. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Rowe, C. A. Argmann, J. Y. Edwards, C. G. Sawyez, O. H. Morand, R. A. Hegele, and M. W. Huff Enhanced Synthesis of the Oxysterol 24(S),25-Epoxycholesterol in Macrophages by Inhibitors of 2,3-Oxidosqualene:Lanosterol Cyclase: A Novel Mechanism for the Attenuation of Foam Cell Formation Circ. Res., October 17, 2003; 93(8): 717 - 725. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Schroepfer Jr. Oxysterols: Modulators of Cholesterol Metabolism and Other Processes Physiol Rev, January 1, 2000; 80(1): 361 - 554. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Mitchell and R. J. Cenedella Human Lens Cholesterol Concentrations in Patients Who Used Lovastatin or Simvastatin Arch Ophthalmol, May 1, 1999; 117(5): 653 - 657. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Gardner, H. Shan, S. P. T. Matsuda, and R. Y. Hampton An Oxysterol-derived Positive Signal for 3-Hydroxy- 3-methylglutaryl-CoA Reductase Degradation in Yeast J. Biol. Chem., March 16, 2001; 276(12): 8681 - 8694. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |